RAC-OST-POL Study population based Polish epidemiological study on postmenopausal osteoporosis prof. dr hab. n. med. Wojciech Pluskiewicz Medical University.

Slides:



Advertisements
Similar presentations
Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

Osteoporosis 9 th January 2013 Dr Julian Tomkinson.
MENOPAUSE CURRICULUM SLIDE SET. What is menopause? Menopause is a normal, natural event, defined as the final menstrual period (FMP), confirmed after.
The FRAX tool for Osteoporosis Should all GP’s be calculating the Frax score prior to treatment Dr Sanjeev Patel Consultant Physician & Senior Lecturer.
Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.
Physical Activity and Bone Health during Childhood and Adolescence: Critical Periods for the Prevention of Osteoporosis Suggested Links (click below)
WHO Osteoporosis Definition (1996)
Hip Fracture Dr Janet Lippett Consultant Orthogeriatrician October 2011.
Downloaded from 1 Alendronate vs. Risedronate Comparison Trial.
Protelos Long-Term Antifracture Efficacy. Protelos Vertebral Antifracture Efficacy over 4 years in SOTI Favors Protelos  RR P
Osteoporosis Lucy Cowdrey 4 th November What is it?
Osteoporosis UBC Internal Medicine Program Dr. Mark Fok Dr. Maria Ashley.
Treatment. Bisphosphonates Promotes bone formation and decreases bone resorption Mechanism of Action First line treatment for osteoporosis in both men.
The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:
Lifetime Veganism: Osteoporosis and Vertebral fracture 1 Thuc Lan Ho-Pham, 2 Nguyen ND, 3 Thu A. Le, 2 Tuan V. Nguyen *Coauthors:, 1 Vu BQ, 3 Pham NH,
Identification of individuals at high- risk of fracture Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
“Known knowns, known unknowns, unknown unknowns….. Ronald Dumsfeld Senior Lecturer in Metabolic Bone Diseases.
1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium... 1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium...
Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women’s Health Initiative (WHI) Chlebowski RT et al. SABCS 2009; Abstract 21.
The Different Modalities of Treatment of Osteoporosis Fracture Kuo-Ti Peng, M.D. Kuo-Ti Peng, M.D. Department of Orthopedics, Chang Gung Memorial Hospital.
Risk factors for hip fracture in men l Low BMD and RF for low BMD l Previous fractures l Low body mass l Taller l Frequent falls and RF for falls.
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
Osteoporosis Slide show
College of Health Sciences Medical Diagnostic Imaging Department Seminar to MDI Done by: Munasser dakam Munasser dakam Jaber hussain Nasser saleh Mohammed.
Fracture risk assessment
A Look at Osteoporosis Screening Guidelines Cynthia Phelan PGY
Genetic-Environmental Interaction: Implications for Osteoporosis Prevention Strategies.
Pathogenesis of Osteoporotic Fracture LOW PEAK BONE MASS LOW PEAK BONE MASS POSTMENOPAUSAL BONE LOSS POSTMENOPAUSAL BONE LOSS AGE-RELATED BONE LOSS.
UNIVERSITY of DERBY Implementing TA 161 and 204 in the real world Dr. Jonathan Bayly Visiting Fellow, University of Derby.
Estrogen plus Progestin, BMD and Fractures: Women’s Health Initiative Jane A. Cauley University of Pittsburgh JAMA 2003; 290 (13) :
11 Quick Facts about Osteoporosis in Long-Term Care Homes Prevalence in LTC Who is at risk in LTC? Leading cause of fractures Reason for admission to LTC.
Osteoporosis Armed Forces Academy of Medical Sciences.
Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.
Osteoporosis: Measuring the Problem
Alimohammad Fatemi Assistant Professor of Rheumatology 1.
Prediction of Hip Fracture in Elderly Men and Women by Fall-related Factors ND Nguyen, C Pongchaiyakul, JR Center, JA Eisman, TV Nguyen Bone and Mineral.
COMMON LIFESTYLE DISEASES: OSTEOPOROSIS
Prevention and Treatment of Osteoporosis
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Chapter 47 Assessing Fracture Risk: Who Should Be Screened? © American Society for Bone and Mineral Research Contributed by John Schousboe, Brent Taylor,
Osteopenia and Osteoporosis Bradley K. Harrison, MD.
NICE, FRAX & NOGG VTS meeting Jonathan Day 7 th April 2010.
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
OSTEOPOROSIS Dr Annie Cooper Consultant Rheumatologist Royal Hampshire County Hospital Winchester.
R1 김형오 / Prof. 김덕윤 1.  Osteoporosis  Asian region is considered to be on the verge of an emerging osteoporosis epidemic  50% of the world’s osteoporotic.
Osteopenia and Osteoporosis
Treatment of Vitamin D Insufficiency in Postmenopausal Women: A randomized clinical trial Journal Club 1/8/2016 Sharda Mukunda.
Possible malnutrition in the elderly in developed countries
Rational Use of DXA-BMD
2016 World Osteoporosis Day Report
OSTEOPOROSIS Florence TREMOLLIERES, MD, PhD
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.
Chapter 55: Cost-Effectiveness of Osteoporosis Treatment
Post Menopausal Osteoporosis
Goal-directed Treatment for Osteoporosis
Osteoporosis Diagnosis 9/21/2018 OSTEOPOROSIS.
Osteoporosis Definition
OSTEOPOROSIS. OSTEOPOROSIS Osteoporosis Osteoporosis affects both men and women. Its prevalence increases with age, and it is particularly common in.
Case for androgens Giorgio Arnaldi Clinica di Endocrinologia
Guidance for Bone Health in Parkinson's
2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub ahead of print].
Deciding on Pharmacological Treatment Post Fracture
Deciding on Pharmacological Treatment Post Fracture
Osteoporosis: Definition
Chapter 44 Osteoporosis: The Early Years
Figure 1. Relative risks of vertebral, hip, and nonvertebral fractures (and 95% CIs) in response to the treatments for ... Figure 1. Relative risks of.
Maintaining bone health while on ADT for Prostate Cancer
Presentation transcript:

RAC-OST-POL Study population based Polish epidemiological study on postmenopausal osteoporosis prof. dr hab. n. med. Wojciech Pluskiewicz Medical University of Silesia, Metabolic Bone Diseases Unit in Zabrze Katowice, Poland Kraków - April 2018 1 1 1

RAC-OST-POL Study The study was planned in 2009 in order to collect data for postmenopausal osteoporosis. (RAC)-IBÓRZ – a name of district capital city (OST)-EOPOROSIS (POL)-AND 2 2 2

RAC-OST-POL Study Design – population based epidemiological study Population – postmenopausal women aged>55 yrs.; 10% of 17,500 all subjects living in whole disctrict were invited Data for 978 women were collected Study was realized in May 2010. 3 3 3

RAC-OST-POL Study At baseline almost 200 of potential risk factors for osteoporosis and fractures were collected Afterwards, annually data on fractures, falls and management used were collected by phone calls. 4 4 4

RAC-OST-POL Study - aims Epidemiological data Diet Falls Vision impairment Functional status Risk factors for osteoporosis and fracture Development of algorithm for fracture risk. 5 5 5

RAC-OST-POL Study - publications 1. Epidemiological data on osteoporosis in women from the RAC-OST-POL study. W. Pluskiewicz et al.. J.Clin.Densitom.2012; 15 (3): 308-314. 2. Adiponectin and resistin in relationship with skeletal status in women from the RAC-OST-POL study. W. Pluskiewicz et al. Pol.J.Endocrinol.2012; 63 (6): 427-431. 3. Calcium intake and osteoporosis: the influence of calcium intake from dairy products on hip bone mineral density and fracture incidence - a population-based study in women over 55 years of age. D. Włodarek et al. Public Health Nutr .2014; 17 (2): 383-389. 4. Influence of education, marital status, occupation, and the place of living on skeletal status, fracture prevalence, and the course and effectiveness of osteoporotic therapy in women in the RAC-OST-POL Study. W. Pluskiewicz et al. J.Bone Miner.Metab 2014; 32 (1): 89-95. 5. Functional status and prevalence of falls and fractures in population-based sample of postmenopausal women from the RAC-OST-POL Study. B. Drozdzowska et al. Int.J.Clin.Pract.2013; 67 (7): 673-681. 6. Common ophthalmic problems of urban and rural postmenopausal women in a population sample of Raciborz district, a RAC-OST-POL Study. W. Rokicki et al. Ann.Agric.Environ.Med.2014; 21 (1): 70-74. 6 6 6

RAC-OST-POL Study - publications 7. High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study. W. Pluskiewicz et al. Osteoporos.Int.2015; 26 (12): 2811-2820. 8. Relationship between visual status and functional status and the risk of falls in women. The RAC-OST-POL study.W. Rokicki et al. Arch.Med.Sci.2016; 12 (6): 1232-1238. 9. Falls in RAC-OST-POL Study: epidemiological study in postmenopausal women aged over 55 years. W. Pluskiewicz et al. Endokrynol.Pol.2016; 67 (2): 185-189. 10. Assessment of mineral intake in the diets of Polish postmenopausal women in relation to their BMI-the RAC- OST-POL study: Mineral intake in relation to BMI. Dominika Głąbska et al. Publ. Popul.Nutr.2016; 35 (23): 1-12. 11. The study of under- and over-sampling methods' utility in analysis of highly imbalanced data on osteoporosis M. Bach et al. Inform.Sci.2017; 384: 174-190. 12. Risk factors for fractures identified in the algorithm Developed in 5-Year Follow-Up of Postmenopausal Women From RAC-OST-POL Study.P. Adamczyk et al. J.Clin.Densitom.2017, p.1-7. 13. Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: A systematic review and meta-analysis. X. Jiang et al. Bone2017; 9:.20-25.

Results – epidemiological data 28% of subjects studied had prior osteoporotic fracture after the age of 40 years 9.6% of women had Femoral Neck BMD T- score <-2.5 6.7% subjects were treated. 8 8 8

Results - diet Mean daily calcium intake was 425±270 mg Mean calcium intake was significantly lower in subjects with osteoporosis (360±226 mg versus 431±263 mg, p<0.01) Mean calcium intake was significantly lower in subjects with prior fracture (390±256 mg versus 438±273 mg, p<0.05). 9 9 9

Results - falls Falls were the most common risk factor for fracture (34%) of subjects studied Falls were also common in 7-years follow-up In follow-up falls were present mostly in subjects with prior fall. 10 10 10

Results – functional status Mean duration of Stand and Up test was significantly greater subjects with prior fracture than in non-fractured subjects (12.4±6.8 sec. versus 11.0±3.2 sec., p<0.001) Mean duration of Stand and Up test was significantly greater subjects with fall than in subjects without fall (12.2±5,2 sec. versus 10.9±4.2 sec, p<0.01). 11 11 11

Results – clinical risk factors for fracture at baseline Falls – 34% Prior fracture – 28% Early menopause – 15% Smoking – 11% Hip fracture in parents – 7% Secondary reasons – 6% Steroid use – 5% 12 12 12

Polish algorithm for fracture risk – baseline data and follow-up Baseline data on potential risk factors for osteoporosis and fractures including hip BMD Annually were collected by phone data on fractures, falls and treatment. W. Pluskiewicz i wsp. J Clin Densitom 2017 13 13 13

Polish algorithm for fracture risk – fractures in follow-up In years 2010-2015 were 78 fractures in 92 women Final analysis was performed in 82% of baseline group (n=802). 14 14 14

Polish algorithm for fracture risk – significant risk factors Steroid use (at least 5 mg of prednison for 6 weeks) Prior fracture after the age of 40 years Falls in last 12 months Femoral Neck BMD Height. 15 15 15

Polish algorithm for fracture risk – equation Risk of fracture incidence = 11+e(9.899+1.077∗STEROIDS+0.681∗PRIO R FALLS+0.611∗PRIOR FRACTURES- 0.483∗FN T-score+0.042∗HEIGHT) 16 16 16

Polish algorithm for fracture risk www.ryzyko-zlaman.pl concerns all osteoporotic fractures for 5 years in women aged over 55 years. 17 17 17

Polish algorithm for fracture risk Result may be helpful in daily practice Always final management decision should be individualised In 3 years after a 10 years of observation an algorithm for a decade will be available. 18 18 18

Polish algorithm for fracture risk -limitations Due the low number of hip fx. separate risk for this skeletal site is not available Spine radiograms were not routinely performed so some spine fx. might be not identified Duration of observation is limited to 5 years Only women were included. 19 19 19

Polish algorithm for fracture risk - strenghts Population studied was randomly selected At baseline almost 200 of potential risk factors were collected All phone calls were performed by one, experienced person. 20 20 20

Campus of Medical University of Silesia Thank you for attention 16.03.17 21 21 21 21 21